ANIXA BIOSCIENCES, INC. Diluted Shares Outstanding (Weighted Average)
ANIXA BIOSCIENCES, INC. (ANIX) reported Diluted Shares Outstanding (Weighted Average) of 34.18 million shares for the 3-month period ending 2026-07-31, per its 10-Q filed 2026-09-09.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-09-09
- ANIXA BIOSCIENCES, INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-07-31 was 34.18M shares, a 5.25% increase year-over-year.
- ANIXA BIOSCIENCES, INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-04-30 was 33.59M shares, a 4.32% increase year-over-year.
- ANIXA BIOSCIENCES, INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-01-31 was 33.24M shares, a 3.24% increase year-over-year.
- ANIXA BIOSCIENCES, INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-10-31 was -96.75M shares.
- ANIXA BIOSCIENCES, INC. weighted average number of shares outstanding, diluted for fiscal 2025 was 32.45K shares, a 1.74% increase from fiscal 2024.
- ANIXA BIOSCIENCES, INC. weighted average number of shares outstanding, diluted for fiscal 2024 was 31.90K shares, a 2.96% increase from fiscal 2023.
- ANIXA BIOSCIENCES, INC. weighted average number of shares outstanding, diluted for fiscal 2023 was 30.98K shares, a 2.00% increase from fiscal 2022.
- ANIXA BIOSCIENCES, INC. weighted average number of shares outstanding, diluted for fiscal 2022 was 30.37K shares, a 99.89% decline from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 6 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 9 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 12 month | Weighted Average Number of Shares Outstanding, Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-07-31 | 34.18M shares 10-Q · filed 2026-09-09 | 33.89M shares derived: average of 2 quarters · filed 2026-09-09 | 33.67M shares 10-Q · filed 2026-09-09 | 1.07M shares derived: average of 4 quarters · filed 2026-09-09 | ||||
| 2026-04-30 | 33.59M shares 10-Q · filed 2026-06-10 | 33.41M shares 10-Q · filed 2026-06-10 | -9.97M shares derived: average of 3 quarters · filed 2026-06-10 | 639.95K shares derived: average of 4 quarters · filed 2026-09-09 | ||||
| 2026-01-31 | 33.24M shares 10-Q · filed 2026-03-09 | -31.75M shares derived: average of 2 quarters · filed 2026-03-09 | -10.34M shares derived: average of 3 quarters · filed 2026-09-09 | 292.20K shares derived: average of 4 quarters · filed 2026-09-09 | ||||
| 2025-10-31 | -96.75M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-01-12 | -32.14M shares derived: average of 2 quarters · filed 2026-09-09 | -10.69M shares derived: average of 3 quarters · filed 2026-09-09 | 32.45K shares 10-K · filed 2026-01-12 | ||||
| 2025-07-31 | 32.48M shares 10-Q · filed 2026-09-09 | 32.34M shares derived: average of 2 quarters · filed 2026-09-09 | 32.29M shares 10-Q · filed 2026-09-09 | 397.65K shares derived: average of 4 quarters · filed 2026-09-09 | ||||
| 2025-04-30 | 32.20M shares 10-Q · filed 2026-06-10 | 32.20M shares 10-Q · filed 2026-06-10 | -10.30M shares derived: average of 3 quarters · filed 2026-06-10 | 292.15K shares derived: average of 4 quarters · filed 2026-06-10 | ||||
| 2025-01-31 | 32.20M shares 10-Q · filed 2026-03-09 | -31.54M shares derived: average of 2 quarters · filed 2026-03-09 | -10.34M shares derived: average of 3 quarters · filed 2026-03-09 | 220.15K shares derived: average of 4 quarters · filed 2026-03-09 | ||||
| 2024-10-31 | -95.28M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-01-12 | -31.62M shares derived: average of 2 quarters · filed 2026-01-12 | -10.44M shares derived: average of 3 quarters · filed 2026-01-12 | 31.90K shares 10-K · filed 2026-01-12 | ||||
| 2024-07-31 | 32.05M shares 10-Q · filed 2025-09-10 | 32.05K shares 10-Q · filed 2024-09-06 | 31.98M shares derived: average of 2 quarters · filed 2025-09-10 | 31.80M shares 10-Q · filed 2025-09-10 | 31.80K shares 10-Q · filed 2024-09-06 | 23.86M shares derived: average of 4 quarters · filed 2025-09-10 | ||
| 2024-04-30 | 31.91M shares 10-Q · filed 2025-05-28 | 31.91K shares 10-Q · filed 2024-06-04 | 31.68M shares 10-Q · filed 2025-05-28 | 31.68K shares 10-Q · filed 2024-06-04 | 21.13M shares derived: average of 3 quarters · filed 2025-05-28 | 15.86M shares derived: average of 4 quarters · filed 2025-05-28 | ||
| 2024-01-31 | 31.45M shares 10-Q · filed 2025-03-11 | 31.45K shares 10-Q · filed 2024-03-12 | 15.74M shares derived: average of 2 quarters · filed 2025-03-11 | 10.50M shares derived: average of 3 quarters · filed 2025-03-11 | 7.88M shares derived: average of 4 quarters · filed 2025-03-11 | |||
| 2023-10-31 | 31.10K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-01-10 | 31.04K shares derived: average of 2 quarters · filed 2025-01-10 | 31.00K shares derived: average of 3 quarters · filed 2025-01-10 | 30.98K shares 10-K · filed 2025-01-10 | ||||
| 2023-07-31 | 30.97K shares 10-Q · filed 2024-09-06 | 30.95K shares derived: average of 2 quarters · filed 2024-09-06 | 30.94K shares 10-Q · filed 2024-09-06 | 30.90K shares derived: average of 4 quarters · filed 2024-09-06 | ||||
| 2023-04-30 | 30.93K shares 10-Q · filed 2024-06-04 | 30.92K shares 10-Q · filed 2024-06-04 | 30.87K shares derived: average of 3 quarters · filed 2024-06-04 | 30.77K shares derived: average of 4 quarters · filed 2024-06-04 | ||||
| 2023-01-31 | 30.92K shares 10-Q · filed 2024-03-12 | 30.84K shares derived: average of 2 quarters · filed 2024-03-12 | 30.71K shares derived: average of 3 quarters · filed 2024-03-12 | 30.57K shares derived: average of 4 quarters · filed 2024-03-12 | ||||
| 2022-10-31 | 30.76K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-01-16 | 30.61K shares derived: average of 2 quarters · filed 2024-01-16 | 30.46K shares derived: average of 3 quarters · filed 2024-01-16 | 30.37K shares 10-K · filed 2024-01-16 | 30.37M shares 10-K · filed 2023-01-04 | |||
| 2022-07-31 | 30.45K shares 10-Q · filed 2023-09-06 | 30.30K shares derived: average of 2 quarters · filed 2023-09-06 | 30.24K shares 10-Q · filed 2023-09-06 | 28.58M shares derived: average of 4 quarters · filed 2023-09-06 | ||||
| 2022-04-30 | 30.15K shares 10-Q · filed 2023-06-14 | 30.15M shares 10-Q · filed 2022-06-10 | 30.14K shares 10-Q · filed 2023-06-14 | 30.14M shares 10-Q · filed 2022-06-10 | 38.10M shares derived: average of 3 quarters · filed 2023-06-14 | 28.58M shares derived: average of 4 quarters · filed 2023-06-14 | ||
| 2022-01-31 | 30.13K shares 10-Q · filed 2023-03-17 | 30.13M shares 10-Q · filed 2022-03-11 | 57.13M shares derived: average of 2 quarters · filed 2023-03-17 | 38.10M shares derived: average of 3 quarters · filed 2023-03-17 | 35.74M shares derived: average of 4 quarters · filed 2023-03-17 | |||
| 2021-10-31 | 114.23M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-01-04 | 57.13M shares derived: average of 2 quarters · filed 2023-01-04 | 47.64M shares derived: average of 3 quarters · filed 2023-01-04 | 28.58M shares 10-K · filed 2023-01-04 | ||||
| 2021-07-31 | 30.45K shares 10-Q · filed 2022-09-09 | 14.35M shares derived: average of 2 quarters · filed 2022-09-09 | 28.09K shares 10-Q · filed 2022-09-09 | |||||
| 2021-04-30 | 28.67M shares 10-Q · filed 2022-06-10 | 26.89M shares 10-Q · filed 2022-06-10 | ||||||
| 2021-01-31 | 25.16M shares 10-Q · filed 2022-03-11 | |||||||
| 2018-04-30 | 16.71M shares 10-Q · filed 2018-06-11 | |||||||
| 2017-04-30 | 9.74M shares 10-Q · filed 2018-06-11 | |||||||
| 2016-04-30 | 8.74M shares 10-Q · filed 2017-05-26 | 8.73M shares 10-Q · filed 2016-05-20 | ||||||
| 2016-01-31 | 8.73M shares 10-Q · filed 2016-02-19 | |||||||
| 2015-07-31 | 8.79M shares 10-Q · filed 2015-08-18 | 9.43M shares derived: average of 2 quarters · filed 2016-05-20 | 9.37M shares derived: average of 3 quarters · filed 2016-05-20 | |||||
| 2015-04-30 | 10.06M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-05-20 | 9.66M shares 10-Q · filed 2016-05-20 | 241.45M shares 10-Q · filed 2015-05-22 | |||||
| 2015-01-31 | 9.25M shares 10-Q · filed 2016-02-19 | 231.29M shares 10-Q · filed 2015-03-09 | ||||||
| 2014-07-31 | 10.63M shares 10-Q · filed 2015-08-18 | 111.75M shares derived: average of 2 quarters · filed 2015-08-18 | 144.58M shares derived: average of 3 quarters · filed 2015-08-18 | |||||
| 2014-04-30 | 212.88M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-05-22 | 211.55M shares 10-Q · filed 2015-05-22 | ||||||
| 2014-01-31 | 210.23M shares 10-Q · filed 2015-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 |